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Abstract 
Background: Infection and death of health care workers (HCWs) with 
COVID-19 is an important health problem and will lead to inadequate 
care of patients, causes more damage and more spread of this 
pandemic. This study aimed to combine data on COVID-19 infection 
among HCWs through a systematic review and meta-analysis study. 
Methods: We searched PubMed via MEDLINE, the SCOPUS, and Web 
of science (ISI) to identify the studies on the prevalence of HCWs 
infection among COVID-19 patients. We used an eight-item checklist 
critically appraised to assess the quality of publications on the COVID-
19 infection among HCWs. Random-effect models and meta-regression 
were used for the meta-analysis of the results. 
Results: Overall, 98 articles were retrieved from the databases, of 
which, seven met the eligibility criteria published between December 
2019 to March 2020. The total sample size of the included studies 
contained 72677 COVID-19 confirmed cases, of which 3131 were 
HCWs. The pooled COVID-19 infection prevalence among HCWs was 
4% (95% CI: 3% to 5%). 
Conclusions: According to the results, COVID-19 infection in HCWs 
was 4% of all cases in the early phase of the pandemic. So HCWs need 
special care including regular screening and appropriate, adequate, 
and standard personal protective equipment (PPE). 
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Introduction 
Severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) or COVID-19 is the cause of an emerging infectious 
disease with significant pulmonary involvement.1 The disease 
was first detected in Wuhan, China, in December 2019, and on 
the 11th of March 2020, it was declared to be a pandemic by 
the world health organization (WHO).2 Similar to other 
infectious diseases, health care workers (HCWs) are at the 
frontline of the fight against COVID-19. Hazards such as 
exposure to pathogens, working long hours, psychological 
stress, fatigue, occupational burnout, stigma, and physical and 
psychological violence can increase HCWs' risk of infection.3 
Transmission of infectious diseases such as severe acute 
respiratory syndrome (SARS), middle east respiratory 
syndrome (MERS), and Influenza within the healthcare 
workers was well documented.4-8 In the case of COVID-19, as 
of the 8th of April 2020, about 20,073 healthcare workers were 
infected in 52 countries.9 
During the COVID-19 pandemic, HCWs are expected to 
work long hours under significant pressure with often 
inadequate resources, while accepting the dangers inherent in 
close interaction with patients. Moreover, HCWs, like everyone 
else, are exposed to the disease and to rumors and incorrect 
information that necessarily decrease their mental health 
levels.10 So, health care workers and researchers across all 
disciplines must be aware of the potential impact this disease 
can have on their respective health fields and the medical 
community at large.11 Furthermore, reliable data on the 
percentage of HCWs among COVID-19 cases can assist us to 
better understand the nature of disease transmission. Designing 
an effective infection prevention plan and controlling measures 
to maximize HCWs' safety in healthcare facilities should be our 
priority. This requires an estimate of the prevalence of COVID-
19 cases among HCWs. To the best of our knowledge, no 
pooled estimate of COVID-19 infection in HCWs is published 
so far. This study aimed to estimate the proportion of patients 
with COVID-19 infection who were HCWs. 
Materials and Methods  
The present systematic review and meta-analysis were 
conducted following the preferred reporting items for 
Systematic reviews and meta-analyses (PRISMA) statement.12 
A comprehensive systematic search of the literature was 
performed to find studies on the COVID-19 infection among 
HCWs. We searched PubMed/MEDLINE, SCOPUS, and Web 
of Science (ISI) databases by combining sets of related MeSH 
and Non-MeSH terms of "COVID-19" or "New Coronavirus" 
and "Health/HealthCare/Medical Staff" or "Health/ HealthCare 
Worker/s" or "Health/HealthCare Professionals" or 
"Health/HealthCare Personnel" to find any relevant studies 
until March 28th, 2020, limited to the English language. We 
further searched Google scholar for additional information on 
the infected HCWs. Studies were eligible for our review if they 
met the following criteria: original studies with Observational 
design; studies on HCWs’ infection among patients with 
COVID-19, and studies that diagnosed COVID-19 infection 
with standard tests. Two authors independently searched in 
relevant databases, two authors screened title/abstracts, then 
reviewed the full texts of the studies, and discrepancies were 
resolved by discussing with the third author. The references of 
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eligible articles were also manually reviewed for other possibly 
related articles that were not found in the electronic search.  
An eight-item checklist for the critical appraisal,13 was used 
to examine the quality of eligible studies by two independent 
investigators. This tool defines eight following criteria.1) 
whether a random sample or whole population was used; 2) if 
an unbiased sampling frame was used; 3) adequacy of the 
sample size; the use of standard measures; 4) whether outcome 
measurements were made by unbiased assessors; 5) adequacy 
of the response rate; 6) confidence intervals (CIs) and subgroup 
analyses; and 8) whether the study subjects were described. 
Each item was scored as one if a study met the criterion and 
zero otherwise, and the scores were summed up. The range of 
the total score was from 0 (lowest possible quality) to 8 
(highest possible quality). The studies' quality is defined as 
high-quality (score≥7), medium-quality (score between 4 and 
6), or low-quality (score<4). The quality assessment results 
were also confirmed by the third investigator. Two of the co-
authors extracted the following data from included studies, 
independently: Author, study date, country, mean age of 
participants, gender, the total number of HCWs, total number 
of HCWs infected with COVID-19, the total number of deaths 
among HCWs infected with COVID-19, COVID-19 infection 
among HCWs and its correspondence 95% confidence interval. 
The extracted data were compared, and discrepancies were 
discussed to reach a consensus. The number of patients and the 
total number of HCWs infected with COVID-19 disease were 
used to calculate the proportion of HCWs’ infection among 
patients with COVID-19 (in logic form) and its corresponding 
standard error (SE).  
The summary pooled proportion with 95% CI was obtained 
using the random-effects model. Person-day in a paper refers to 
a unit of measurement, especially in accountancy, based on an 
ideal amount of work done by one person in one working day. 
Cochran's Q test was used to identify the heterogeneity of the 
results, and it was quantified using the I2 statistic, which was 
above 50% or Q statistics with Pvalue<0·10 were considered as 
a significant between-study heterogeneity. Moreover, the 
between-study variance was assessed using the tau-squared 
(Tau2 or T2) statistic.14 
A jack-knife sensitivity analysis was conducted by 
removing the studies from meta-analyses one by one. We also 
evaluated the publication bias using Begg's funnel plots and the 
asymmetry tests (Egger's and Begg's test). All statistical 
analyses were performed using STATA software (STATA; version 
14). Pvalues less than 0.05 were considered statistically significant. 
Results 
As described in figure1, according to the PRISMA flow chart, 
a total of 98 studies were extracted by electronic and manual 
searching. Of these, 13 were excluded because of duplication. 
From the remaining 85 articles, 56 were excluded after titles and 
abstracts were assessed. Therefore, 29 studies remained to be 
carefully checked by examining the full texts, of which 22 articles 
were excluded for the following reasons: no relevant data (n=11), 
did not report the outcome of interest (n=2), did not report the 
COVID on HCWs (n=27). Finally, seven studies were included in 
qualitative synthesis, out of which seven 15-21 met our eligibility 
criteria and were included in the systematic review and meta-
analysis. The main characteristics of the included studies are 
described in table 1.  
Table 1. The main characteristics of the studies included in the present systematic review and meta-analysis 
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Figure 1. PRISMA flow diagram of studies included and excluded at each stage of screening 
The seven relevant articles15-21 were published from 11th Dec. 
2019 to 28th Feb 2020 (the search was from 1st Dec 2019 till 28th 
March 2020). They consisted of 72677 patients, among which 3131 
were HCWs with COVID-19. The lowest proportion of HCWs  ̀
infection with COVID-19 was reported by Wang G et al. 
(Prevalence=0.01, 95%CI: 0.00, 0.04)20 and the highest rate was 
reported 29% by Wang D et al., (0.29, 95%CI: 0.22, 0.37).19 Most 
studies were cross-sectional15-18,21 in design except two case-series.19,20 
According to critical appraisal, all studies were assigned as 
"high quality"15,17-21 except one as "moderate quality".16 The results 
of methodological quality assessment are shown in table 2. Results 
of the random effect meta-analysis revealed that the pooled 
proportion of HCWs  ̀ infection with COVID-19 was 4% 
(prevalence=0.04, 95%CI: 0.03, 0.05) with a significant 
heterogeneity (I2=94.99%, Pvalue<0.001)(Figure 2). 
We used the funnel plot and Egger test to assess publication bias. 
As presented in figure 3, no significant publication bias was found 
(t=25.31, Pvalue=0.08). Also, the results of sensitivity analysis 
suggest consistency with the result of pooled estimates of the 
prevalence after removing single studies. 
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Figure3. Funnel plot of studies included in the meta-analysis 
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Table 2. Results of risk assessment bias using guidelines for critically appraising studies of prevalence or incidence of a health problem 
Study 
Are the study methods valid? 
What is the 
interpretation of 
the results? 
































































































































































































































































































































































Wang, D. et al.19. * * * * * * * * 8 
Zhang et al.21 * * * * * * * * 8 
Wang C et al. 18 * * * * * * - * 7 























Qui Li et.al 16 * * * * * * - * 7 
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Discussion 
Our hypothesis was to measures the prevalence of COVID- 
19 diseases in healthcare workers among patients via a 
systematic review and meta-analysis. Because they are on the 
front lines fighting COVID-19 every single day, hour by hour, 
minutes by minutes, and are at considerable risk. They would 
need tremendous support and care. Moreover, due to the nature 
of their work, they could be potential carriers, infecting others. 
Hence, the control of infection among HCWs is of great 
importance to control transmission in the community. 
Heterogeneity in the transmission is one of the characteristics 
of SARS and MERS epidemics, and especially the incidence of 
super-distribution events, particularly in hospitals.22 
Our findings based on meta-analysis, on seven papers, 
indicated that the proportion of HCWs’ infection among 
patients is 4% (95% CI: 3% to 5%). A study showed that while 
health care professionals are identified as high-risk groups, the 
frequency of Covid-19 infection has not been as great as cases 
identified among this group during the period of the SARS 
(33% in Meriland, China) and MERS epidemics.23  
The first cases of COVID-19 disease were reported in 
China. The seven included studies during the first months of 
this pandemic (11 Dec.2019 to 28 Feb.2020) also were from 
this country.15-21 Reporting the characteristics of the disease, 
including ways of transition, severity, trends, and proportion of 
HCWs’ infection among patients, can help us strategize 
preventive measures and reduce the rate in this working group. 
Included papers in our systematic review have reported 
characteristics of the prevalence of COVID-19 in HCWs in 
four categories as follows:  
1. Methods of transmission  
The highest prevalence of COVID-19 among healthcare 
workers was 29% in Wuhan hospital in China. Among these 
groups of healthcare workers, no one worked in an isolated 
ward for COVID-19; they worked in the emergency 
department, intensive care unit (ICU), and general wards. A 
patient admitted to the surgery ward with abdominal pain was 
able to infect ten hospital staff and 4 patients.16 This event 
occurred in the early stages of the pandemic disease and maybe 
abdominal pain was not recognized as a symptom of this 
disease.  
Wang G. et al. indicated that three healthcare workers were 
infected among patients; one medical practitioner worked in a 
community health center and was responsible for monitoring 
the temperature of people from Wuhan. One was infected 
during this period, whereas another one was infected through 
her family. There was no confirmed case of infection among 
health care workers in the isolation ward of the public health 
treatment, center of Changsha, by Feb 20th.20 At present, with a 
recognition of more than ten symptoms for COVID-19 and 
early detection of the patients with PCR laboratory test, we 
expected to prevent the transmission from late-diagnosed 
patients and in the other wards of hospitals to healthcare 
workers.  
2. The severity of COVID-19 among healthcare workers 
Jin-jin Zhang from Jan 2019 to Feb 3rd, 2020 in no.7 
hospital of Wuhan found that infected Hospital staff was %2.1 
among total patients, %3.7 in no severe patients, zero in severe 
patients. Also Pvalue for approval severity compared to general 
people was not significant (0.267).21 
Wang C et al., in another study reported that health workers 
were not at the upper risk of severity (OR, 1.12; 95%CI 0.96 to 
1.31) that increased by age.18 In the study by Wang D et al., 
among 138 Covid19 patients, 40 cases were healthcare 
workers, only one was hospitalized in ICU. The differences 
between ICU and non-ICU patients were statistically 
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significant (Pvalue<0.05).19 A study among health workers with 
symptoms of COVID-19 in 2 Dutch hospitals also indicated 
that most HCWs had mild disease.24 This may be related to 
their health knowledge, self-care, and access to appropriate 
medications. 
3. The rate of disease in health workers compared to the 
general population  
The average attack rate in local health workers (144.7 per 
1000,000 people) was largely higher than that of the general 
population (41.7 per 1000,000 people). The prevalence was 
higher in the third phase of the study (507.4 per 1000,000 
people). The highest rate among the health workers reported 
from Jan 11 - Feb 1.18 CDC weekly of China reported that the 
observed person-days were 28,069. The mortality due to 
COVID-19 was 0.002 per 10 person-days was 0.002 from Dec 
31 2019, to Feb 11 2020, among 44672 confirmed cases in 31 
provinces of China.17 
4. Trends of HCWs’ infection among patients with 
COVID-19 
Qun Li et al., in a study in Wuhan among confirmed cases 
of COVID-19, reported the proportion of HCWs’ infection 
among patients increased across the three periods. Before Jan 1 
in 2020, among 47 cases, there were not any HCWs. From Jan 
1 -11 of 2020 among 248 patients, there was %3, and from Jan 
12 - 22 among 122 patients, 7% had infections.16 It seems the 
trend has been upward until Jan 22. Chen et al., in a 
descriptive- retrospective study among 99 patients with 
2019nCoV during Jan 1- 20, 2020, at a specialized hospital 
(Jinyintan] in adults aged ≥14 years in Wuhan, indicated none 
of the patients were healthcare.25 In a study by CDC weekly 
from Dec 2019 to Feb11 among 44672 confirmed cases, the 
epidemic curve increased during 23-26 Jan then declined to 
Feb11. Before Jan 11, 4.1% of patients, Jan 11-22 8.9%, Jan 
23- Feb 1, 4.9 %, Feb 2-18, 3.1 % were healthcare.17 Based on 
the literature in occupational health and medicine, it is quite 
clear that occupational and work-related biological factors such 
as viruses in normal conditions, not only in the pandemic 
conditions of the disease, is one of the most important harmful 
factors in the environment of hospitals, private clinics, etc. 
among the health workers, especially physicians, nurses, 
laboratory staff, cleaners, hospital waste transportation staff, 
laundry, and repair staff, who are in close contact with 
infectious patients.24-26 So, outbreaks of coronavirus-19 in 
health care workers are not unexpected due to the nature of 
their work, exposure to the patients, pathogenic respiratory 
droplets, pathogenic clothing, tools and equipment, and waste. 
Also, psychological problems in the workplace such as high 
workload, exposure to transmissible diseases, insufficient 
personal protective equipment, and the death of patients far 
away from family and worry about children, long, and 
continuous shift work make working conditions more difficult 
for these employees. Therefore, make them susceptible to 
disease.9,24,25 
Our systematic review study indicated the prevalence of 
COVID-19 in health care workers among patients has great 
differences. It seems differences in different studies may be 
related to the definition of healthcare workers in these seven 
papers. The exact job of a health worker was not identified in 
most of these studies. On the other hand, differences may be 
related to lower awareness of healthcare in some hospitals from 
preventive measurement, in the initial situation of disease, 
deficiency of medical resources, including designated wards 
and personal protective equipment in hospitals. Almost in the 
middle of Feb 2020, WHO recommended masks, gloves, 
goggles, gowns, hand sanitizer, soap, and water cleaning 
supplies in sufficient quantity to healthcare for suspected and 
confirmed patients, that is used by them. Because no effective 
treatment or vaccine has been developed for these patients, the 
best way to fight against this virus is to prevent the spread of 
infection and control the sources of infection. The main 
strategies based on the recommendation of WHO are timely 
diagnosis and reporting of the disease, continuous review of the 
epidemiological pattern of the disease, isolation and timely 
treatment of patients, and control measures such as personal 
protective equipment and social distance at the community 
level. Working should be reasonably implemented in the 
hospital among healthcare workers in the rotation shift.  
Our study has some limitations, one of them is that most of 
the included studies are cross-sectional, and data cannot be 
used to infer causality. Others are a low number of studies, 
insufficient sample size, low accuracy of studies at the 
beginning of the epidemic, no specific study in health workers, 
restricted studies to China, and the overlap of some studies. 
The strengths of our study are comprehensive search, 
appropriate search strategy, and to the best of our knowledge, it 
is the first systematic review and meta-analysis study in this 
field. Further research is needed to identify the risk factors for 
the spread of viral infections in workplaces, which can be used 
to plan preventive interventions at the organizational and 
individual levels. In the cohort study, the features of cases 
should continue to be monitored to identify any modifications, 
to identify the risk factors for the spread of viral infections in 
workplaces.  
Our systematic review study indicated the proportion of 
HCWs’ infection among patients is from 1.2% to 29% lead to 
4% in meta-analyses. This has been approved with high 
sensitivity. The rate was higher than the general population, 
severity was mild and lower than the general population, and 
the method of transmission during the study period was 
different in the early situation of this pandemic disease 
compared to the next phases. These studies were all 
accidentally performed in China. Further studies are needed to 
identify other characteristics of this disease among healthcare 
in other countries for the prevention and control of the disease. 
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